BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Names Experienced Researcher as Advisory Board Member
Dec 6, 2022
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has appointed a new scientific advisory board member: Dr. Matthias Dobbelstein, director of the Institute of Molecular Oncology at the University Medical Center Göttingen in Germany since 2005 and also an associate member of the Max Planck Institute for Multidisciplinary Sciences (“MPI-NAT”). During his career, Dobbelstein has amassed impressive experience, particularly with his research, which has focused on principles of infections and cancer. He has studied the application of anticancer drugs as antivirals and has also worked with alpaca-derived NanoAbs, or nanosized antibodies known as nanobodies and VHH antibodies, as therapeutics. Dobbelstein and Dr. Dirk Görlich have provided research that serves as the scientific basis of BiondVax’s exclusive license for development and commercialization of an innovative, self-administered, inhaled NanoAb for the treatment of COVID-19, an approach that indicated significantly milder illness and faster recovery in a recent study. Dobbelstein and Görlich are collaborating with BiondVax to work toward the discovery, characterization and cloning of additional NanoAbs for the treatment of autoimmune diseases such as psoriasis, psoriatic arthritis, asthma and macular degeneration. “We have been enjoying productive scientific cooperation with Professor Dobbelstein over the past year through our collaboration to develop his and Professor Görlich’s translational NanoAb research into a drug candidate for the treatment of COVID-19, which is currently being tested in a preclinical study,” said BiondVax Pharmaceuticals chief science officer Dr. Tamar Ben-Yedidia in the press release. “On behalf of BiondVax’s executive team, I am pleased to welcome Matthias to our SAB and am confident his deep scientific and clinical knowledge will meaningfully contribute to further building BiondVax into an innovative multi-asset pharmaceutical company.”
In addition, BiondVas announced that it has chosen InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, for its communications partner. According to the announcement, IBN will use its investor-based distribution network to generate greater awareness of the company; that network includes more than 5,000 syndication outlets as well as several newsletters, social media channels, wire services, blogs and other outreach tools. “BiondVax is guided by a highly experienced and successful pharmaceutical industry leadership team that includes former senior executives from Novartis, GSK and Bristol-Myers Squibb,” said IBN director of client solutions Chris Johnson in the press release. “We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it moves toward a phase 1/2a clinical trial of its inhaled COVID-19 therapeutic NanoAb in 2023. The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected.”
To view the full press releases, visit https://ibn.fm/gzM58 and https://ibn.fm/WgYGW
About BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals, a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, the company has executed eight clinical trials including a seven-country, 12,400-participant, phase 3 trial of its prior vaccine candidate; the company also has a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information about the company, please visit www.BiondVax.com
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
Burong prutas at gulay, alamin!; Mga amag sa bahay, paano nabubuo? | Dami Mong Alam, Kuya Kim!
Aired (October 3, 2026): Burong mangga at ampalaya, natikman mo na ba? Alamin kung paano ginagawa ang mga ito at kung ano ang kakaibang lasa ng mga pagkaing dumaraan sa proseso ng pagbuburo. Mula sa kusina, tutungo naman tayo sa mga lugar kung saan maaaring tumubo ang amag. Bakit ito kumakapit sa mga pader at pagkain? Maaari ba itong makasama sa kalusugan? At sa kabila nito, may mga amag din kayang may pakinabang? Panoorin ang video.
Mga amag na nakikita sa bahay, mayroon ding pakinabang? | Dami Mong Alam, Kuya Kim!
Aired (October 3, 2026): Ang mga amag na madalas makita sa pagkain, nakikita na rin sa parte ng bahay tulad ng kisame at dingding! Pero alam n'yo ba na may magandang pakinabang daw ito? Panoorin ang video.
Laziest animals na matatagpuan sa iba't ibang panig ng mundo, alamin! | Dami Mong Alam, Kuya Kim!
Aired (October 3, 2026): Ang katamaran, nakikita rin pala sa... hayop? Ilang binansagang 'laziest animals' sa iba't ibang panig ng mundo, alamin! Ano nga ba ang kakaiba sa kanilang kilos at bakit sila binansagang tila 'tamad'? Panoorin ang video.
Mga prutas at gulay na puwedeng iburo, tikman! | Dami Mong Alam, Kuya Kim!
Aired (October 3, 2026): Nakatikim ka na ba ng burong prutas tulad ng mangga o kaya'y burong gulay tulad ng ampalaya? Alamin natin kung ano nga ba ang lasa ng mga burong prutas at gulay na ito! At, paano ang tamang proseso ng paggawa ng buro? Panoorin ang video.
Mga amag, dumikit sa pader ng bahay!; Burong prutas at gulay, tikman! | Dami Mong Alam, Kuya Kim!
Mga amag, dumikit sa pader ng bahay!; Burong prutas at gulay, tikman! | Dami Mong Alam, Kuya Kim! MGA AMAG, DUMIKIT SA PADER AT KISAME NG ISANG BAHAY!; BURONG PRUTAS AT GULAY, TIKMAN! Mga amag, dumidikit rin pala sa pader at kisame ng bahay? Paano nga ba alisin ang mga ito at gaano ito kadelikado sa kalusugan ng tao? Samantala, iba't ibang prutas at gulay na puwedeng iburo, tikman! Paano nga ba ang tamang proseso ng pagbuburo? At, mga hayop na tila tamad raw kung kumilos, alamin! Bakit nga ba kakaiba ang mga kilos ng mga hayop na ito? Panoorin sa #DamiMongAlamKuyaKim!
Stars and creators hit the race course at Pokémon Run 2026
Gotta run 'em all! Pokémon trainers young and old from across the Philippines gathered today for the much-awaited Pokémon Run 2026sat the SM Mall of Asia Complex in Pasay City. Thousands of fans, celebrities, and content creators participated on the first day of this immersive experience, while the second one will happen tomorrow, October 4. The Pokémon company collaborated with race organizer RUNRIO for this one-of-a-kind race event. In a statement, RUNRIO explained that this two-day event is not a competitive race. Instead, it encourages every trainer to explore the beauty of the Pokémon world. Part of the statement read, “Instead of racing against the clock, runners are invited to enjoy a fun-filled 5KM journey through the Pokémon world, exploring iconic regions, discovering exciting surprises and creating unforgettable memories.” READ: Celebs, content creators, and trainers gather at Pokémon anniversary kick off Check out what happened in the immersive Pokémon Run in this gallery.
Alex Gonzaga's first tender moments with Baby Isaac
After three pregnancy losses, Alex Gonzaga is savoring every moment with her first child, Isaac Gerard, whom she welcomed with her husband, Lipa City Vice Mayor Mikee Morada, after years of waiting. LOOK: Alex Gonzaga, Mikee Morada introduce newborn son Isaac Gerard Born on August 8, 2026, Baby Isaac has brought a new chapter to Alex's life as a first-time mom. She has been making the most of motherhood and cherishing the precious moments with her long-awaited baby. Check out the couple's first tender moments with Isaac in this gallery.
Pinoy Big Brother Collab 3.0: BAHAYnihan ni Kuya
Lipat-bahay, bagong buhay, at bagong simula. Mga Kapuso at mga Kapamilya, samahan natin sina Bianca Gonzalez, Robi Domingo, Gabbi Garcia, Melai Cantiveros-Francisco, Enchong Dee, Alexa Ilacad sa BAHAYnihan ni Kuya. Samantala, may bago silang makakasama at makikilala na siya sa darating Lunes, October 5. Abangan ang susunod na updates tungkol sa 'Pinoy Big Brother Collab 3.0' sa GMANetwork.com at iba pang social media accounts ng Kapuso Network.
Nadine Lustre releases new song '10yrs'
Nadine Lustre's new song "10yrs" is dedicated to her 20s.
Photos that show why Dennis Trillo stands out as the best dad ever
Being a father is a life-changing role—one that comes without scripts or rehearsals. For Kapuso Drama King Dennis Trillo, whose life is often shaped by long hours on set, media attention, and unpredictable schedules, being a dad comes with its own unique challenges and deeply personal rewards. Whether he is playing a superhero or delivering powerful lines on screen, Dennis finds that some of his most meaningful moments happen off-camera, at home, with his children.
Travel content creators you should follow now!
Feeling the itch to pack your bags and go on a memorable adventure? Well, you are not alone! According to the data from the Bureau of Immigration (BI), 15,050,136 individuals departed the country in 2024. Out of that number, 8.34 million were Filipinos. Now, if you are looking to find some helpful advice to plan your next travel itinerary, whether you are either flying domestic or abroad-- check out these travel content creators that will surely inspire you to do a bit more exploring. They can also give you important insights about what to do in your dream destination and tips that will make your vacation a whole lot memorable!
Barangay Love Stories: Aking paruparo
Kasalanan ba ang magmahal? E, paano kung ma-in love ka sa isang scammer? Abangan sina Marco Masa at Waynona Collings sa kuwento ng pag-ibig na nagsimula sa dating app sa 'Barangay Love Stories' ngayong Sabado, 4 p.m. sa GMA at Kapuso Stream.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.